Adriano Venditti

Adriano Venditti

UNVERIFIED PROFILE

Are you Adriano Venditti?   Register this Author

Register author
Adriano Venditti

Adriano Venditti

Publications by authors named "Adriano Venditti"

Are you Adriano Venditti?   Register this Author

100Publications

3029Reads

12Profile Views

An evaluation of enasidenib for the treatment of acute myeloid leukemia.

Expert Opin Pharmacother 2019 Nov 27;20(16):1935-1942. Epub 2019 Aug 27.

Cattedra di Ematologia, Dipartimento di Biomedicina e Prevenzione, Università Tor Vergata , Roma , Italia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2019.1654456DOI Listing
November 2019

MRD in AML: The Role of New Techniques.

Front Oncol 2019 23;9:655. Epub 2019 Jul 23.

Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.00655DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664148PMC
July 2019

Novel Agents for Acute Myeloid Leukemia.

Cancers (Basel) 2018 Nov 9;10(11). Epub 2018 Nov 9.

Hematology, Department of Biomedicine and Prevention, "Tor Vergata" University of Rome, 00133 Roma, Italy.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2072-6694/10/11/429
Publisher Site
http://dx.doi.org/10.3390/cancers10110429DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267447PMC
November 2018

Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia.

Cancers (Basel) 2018 Jun 26;10(7). Epub 2018 Jun 26.

Hematology, Department of Biomedicine and Prevention, Tor Vergata University of Rome, 00133 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers10070215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070940PMC
June 2018

Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?

Med Mycol 2018 Apr;56(3):263-278

Dipartimento di Scienze della Salute, Sezione di farmacologia Clinica e Oncologia, Università degli Studi di Firenze oppure Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/mmy/myx053DOI Listing
April 2018

Thrombosis in adult patients with acute leukemia.

Curr Opin Oncol 2017 Nov;29(6):448-454

aHematology, Department of Biomedicine and Prevention, University of Rome 'Tor Vergata' bLaboratory of Tumor Immunology and Immunotherapy, Institute of Translational Pharmacology, Department of Biomedicine, National Research Council (CNR), Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000402DOI Listing
November 2017

Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.

J Chemother 2017 Jun 24;29(3):131-143. Epub 2017 Mar 24.

l Department of Health Sciences, Clinical Pharmacology and Oncology Section , University of Florence , Florence , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1120009X.2017.1306183DOI Listing
June 2017

Emerging strategies for the treatment of older patients with acute myeloid leukemia.

Ann Hematol 2016 Oct 27;95(10):1583-93. Epub 2016 Apr 27.

Department of Hematology, Tor Vergata University Hospital, Viale Oxford 81, 00133, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2666-2DOI Listing
October 2016

Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.

J Transl Med 2016 08 12;14(1):239. Epub 2016 Aug 12.

Laboratory of Tumor Immunology and Immunotherapy, CNR Institute of Translational Pharmacology (IFT), Via Fosso del Cavaliere 100, 00133, L'Aquila, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-016-1001-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983069PMC
August 2016

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial.

J Clin Oncol 2016 Mar 25;34(9):972-9. Epub 2016 Jan 25.

Sergio Amadori, Adriano Venditti, and Maria Teresa Voso, Tor Vergata University; Luciana Annino, San Giovanni Addolorata Hospital; Paolo De Fabritiis, St Eugenio Hospital; Giuliana Alimena and Marco Mancini, Sapienza University; Francesca Paoloni, Marco Vignetti, and Paola Fazi, GIMEMA Foundation, Roma; Franco Aversa, University Hospital, Parma; Gainluca Gaidano, University of Eastern Piedmont, Novara; Maurizio Musso, La Maddalena Clinic, Palermo; Carla Mazzone, Annunziata Hospital, Cosenza; Domenico Magro, Pugliese-Ciaccio Hospital, Catanzaro; Safaa Mahmoud Ramadan, European Institute of Oncology, Milano, Italy; Stefan Suciu and Liv Meert, EORTC Headquarters, Brussels; Dominik Selleslag, AZ St Jan, Brugge; Anne Hagemeijer, KULeuven, Leuven; Frédéric Baron, Centre Hospitalier Universitaire, Liège, Belgium; Petra Muus and Theo de Witte, Radboudumc, Nijmegen; and Roel Willemze, University Medical Center, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/01/21/JCO.2015.64
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.64.0060
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.64.0060DOI Listing
March 2016

NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma.

Front Med (Lausanne) 2015 26;2:33. Epub 2015 May 26.

Laboratory of Tumor Immunology and Immunotherapy, Institute of Translational Pharmacology, CNR , Rome , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2015.00033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469113PMC
July 2015

BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib.

Biochim Biophys Acta 2015 Mar 5;1852(3):462-72. Epub 2014 Dec 5.

Unit of Neuro-Oncohematology, Santa Lucia Foundation-I.R.C.C.S., Rome, Italy; Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2014.12.001DOI Listing
March 2015

Two novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia.

J Mol Diagn 2015 Mar 29;17(2):179-84. Epub 2014 Dec 29.

Department of Biomedicine and Prevention, The University Tor Vergata, Rome, Italy; Neuro-Oncohematology Unit, The Santa Lucia Foundation, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2014.10.003DOI Listing
March 2015

Extensive toxic epidermal necrolysis following brentuximab vedotin administration.

Ann Hematol 2015 Feb 2;94(2):355-6. Epub 2014 Jul 2.

Istituto di Ematologia, Dipartimento di Biomedicina e Prevenzione, Università Tor Vergata, Viale Oxford 81, 00133, Rome, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2148-3DOI Listing
February 2015

Advances in the treatment of elderly and frail patients with acute myeloid leukemia.

Curr Opin Oncol 2014 Nov;26(6):663-9

Department of Hematology, Tor Vergata University Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000124DOI Listing
November 2014

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.

J Clin Oncol 2014 Jan 2;32(3):219-28. Epub 2013 Dec 2.

Roelof Willemze, Constantijn J.M. Halkes, and Erik W.A. Marijt, Leiden University Medical Center, Leiden; Petra Muus, Joop Jansen, and Theo de Witte, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; Stefan Suciu and Liv Meert, European Organisation for Research and Treatment of Cancer Headquarters; Dominique Bron, Hôpital Universitaire, Bordet-Erasme, Brussels; Dominik L.D. Selleslag, Algemeen Ziekenhuis Sint-Jan, Brugge; Zwi Berneman, Universitair Ziekenhuis, Antwerpen; Georges Fillet, Centre Hospitalier Universitaire du Sart-Tilman, Liège; Anne Hagemeijer, Center for Human Genetics, University of Leuven, Leuven, Belgium; Giovanna Meloni, Marco Mancini, Silvia Maria Trisolini, and Franco Mandelli, "Sapienza" University; Sergio Amadori and Adriano Venditti, Tor Vergata University Hospital; Simona Sica, Università Cattolica del Sacro Cuore, Policlinico A. Gemelli; Paola Fazi and Marco Vignetti, Gruppo Italiano Malattie Ematologiche dell' Adulto Foundation, Central Office, Rome; Giorgina Specchia, Università degli Studi di Bari, Bari; Francesco Fabbiano, Ospedali Riuniti "Villa Sofia-Cervello"; Maria Enza Mitra, Policlinico "Paolo Giaccone," Palermo; Francesco Nobile, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria; Marco Sborgia, Azienda Unitá Sanitaria Locale di Pescara, Pescara; Andrea Camera, L'A.O. Universitaria-Università degli Studi di Napoli "Federico II," Napoli; Domenico Magro, A.O. Pugliese Ciaccio, Catanzaro; Nicola Cantore, A.O. San Giuseppe Moscati, Avellino; Lorella Melillo, Istituto Di Ricovero e Cura a Carattere Scientifico Casa Sollievo della Sofferenza, San Giovanni Rotondo; Pietro Leoni, A.O. Nuovo Ospedale Torrette, Ancona; Mario Luppi, A.O. Universitaria di Modena, Modena; Daniela Cilloni, University of Torino, Torino, Italy; Boris Labar, University Hospital Center-Rebro, Zagreb, Croatia; Jean-Pierre Marie, Saint-Antoine Hospital, Assistance Publique-Hopitaux de Paris and University Paris 6; Francois Lef

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.8571DOI Listing
January 2014

Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17).

J Clin Oncol 2013 Dec 14;31(35):4424-30. Epub 2013 Oct 14.

Sergio Amadori and Adriano Venditti, Tor Vergata University Hospital; Paolo De Fabritiis, St Eugenio Hospital; Roberto Latagliata, University Sapienza; Paola Fazi and Marco Vignetti, Gruppo Italiano Malattie Ematologiche dell'Adulto, Roma; Franca Falzetti, University Hospital, Perugia; Domenico Magro, Pugliese Hospital, Catanzaro; Giorgina Specchia, University Hospital, Bari, Italy; Stefan Suciu and Matthias Karrasch, European Organisation for Research and Treatment of Cancer, Brussels; Dominik Selleslag, Algemeen Ziekenhuis St Jan, Brugge; Zwi Berneman, University Hospital, Antwerp, Belgium; Roberto Stasi, St George's Hospital, London, United Kingdom; Helmut R. Salih, University Hospital, Tubingen; Anthony D. Ho, University Hospital, Heidelberg; Michael Lübbert, Albert Ludwigs University, Freiburg, Germany; Petra Muus and Theo de Witte, Radboud University Medical Centre, Nijmegen; Constantijn J.M. Halkes and Roel Willemze, University Medical Center, Leiden, the Netherlands; Xavier Thomas, Edouard Herriot Hospital, Lyon; Jean-Pierre Marie, St. Antoine Hospital, Paris, France; and José E. Guimaraes, University Hospital, Porto, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.0771DOI Listing
December 2013

Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.

Expert Rev Hematol 2013 Dec;6(6):767-84

Haematology and Haematopoietic Stem Cell Transplant Center, AORMN, Marche Nord Hospital, Via Lombroso, 61100 Pesaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2013.858018DOI Listing
December 2013

Azacitidine for the treatment of lower risk myelodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program.

Cancer 2010 Mar;116(6):1485-94

Unit of Hematology and Stem Cell Transplantation, IRCCS, Centro di Riferimento Oncologico della Basilicata, Via Padre Pio 1, 85028 Rionero in Vulture, Potenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24894DOI Listing
March 2010

Monitoring of minimal residual disease in acute myeloid leukemia.

Curr Opin Oncol 2009 Nov;21(6):582-8

Department of Biopatologia e Diagnostica per Immagini, Fondazione Policlinico Tor Vergata and Ospedale S.Eugenio, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e3283311856DOI Listing
November 2009

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia.

Cancer Treat Rev 2008 Feb 17;34(1):49-60. Epub 2007 Oct 17.

Department of Medical Sciences, Ospedale Regina Apostolorum, Regina Apostolorum Hospital, Via S Francesco, 50, Albano Laziale, Italy.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S030573720700135
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2007.09.001DOI Listing
February 2008

Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.

Thromb Haemost 2008 Jan;99(1):4-13

Department of Medical Sciences, Ospedale, Regina Apostolorum Hospital, Albano Laziale, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH07-08-0513DOI Listing
January 2008

Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.

Expert Rev Anticancer Ther 2006 Dec;6(12):1787-800

Cattedra di Ematologia, Università Tor Vergata, Ospedale S.Eugenio, Via Fiume Giallo, 430 MA, 00144 Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.6.12.1787DOI Listing
December 2006

Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia.

Haematologica 2004 Aug;89(8):934-9

Cattedra di Ematologia, Università di Roma Tor Vergata, Divisione di Ematologia, Osp.S.Eugenio, p.le dell'Umanesimo 10, 00144 Rome, Italy.

View Article

Download full-text PDF

Source
August 2004